Catherine J. Spellicy

828 citations

20 papers · 587 indexed · h-index 13

Molecular Biology
Ophthalmology top 5%
Cellular and Molecular Neuroscience top 10%
Epidemiology
Genetics

Co-authors: Stephen P. Daiger Sara J. Bowne Lori S. Sullivan Jingya Zhu David G. Birch Anisa Gire Dianna K. Hughbanks-Wheaton John R. Heckenlively
Topics: Substance Abuse Treatment and Outcomes (5 papers)Neurotransmitter Receptor Influence on Behavior (5 papers)Cytomegalovirus and herpesvirus research (5 papers)
Cited by: Ophthalmology Physiology Molecular Biology
Journals: PLoS ONE Archives of Biochemistry and Biophysics American Journal of Ophthalmology
Partner nations: United States Cyprus Canada

In The Last Decade

Catherine J. Spellicy

20 papers receiving 581 citations

Peers

Countries citing papers authored by Catherine J. Spellicy

Since Specialization

Citations

This map shows the geographic impact of Catherine J. Spellicy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine J. Spellicy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine J. Spellicy more than expected).

Fields of papers citing papers by Catherine J. Spellicy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine J. Spellicy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine J. Spellicy. The network helps show where Catherine J. Spellicy may publish in the future.

Co-authorship network of co-authors of Catherine J. Spellicy

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine J. Spellicy. A scholar is included among the top collaborators of Catherine J. Spellicy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine J. Spellicy. Catherine J. Spellicy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mosaicism of common pathogenic MECP2 variants identified in two males with a clinical diagnosis of Rett syndrome 2022 ·American Journal of Medical Genetics Part A ·(unknown),Timothy Fee,Renee Bend,Raymond J. Louie,Fran Annese,(unknown),(unknown),(unknown),David B. Everman,Steven A. Skinner,Michael J. Friez,Julie R. Jones,Catherine J. Spellicy	5
2	The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients 2021 ·Psychiatric Genetics ·P. Thomas,(unknown),Catherine J. Spellicy,Mark J. Harding,(unknown),Michelle A. Patriquin,Sara Hamon,Thomas R. Kosten,David A. Nielsen	5
3	Pharmacogenetic Role of Dopamine Transporter (SLC6A3) Variation on Response to Disulfiram Treatment for Cocaine Addiction 2019 ·American Journal on Addictions ·(unknown),Catherine J. Spellicy,(unknown),Mark J. Harding,(unknown),Sara Hamon,Thomas R. Kosten,David A. Nielsen	16
4	Three additional patients with EED-associated overgrowth: potential mutation hotspots identified? 2019 ·Journal of Human Genetics ·Catherine J. Spellicy,Yunhui Peng,(unknown),Sara Cathey,R. Curtis Rogers,Dennis Bartholomew,(unknown),Emil Alexov,Jennifer A. Lee,Michael J. Friez,Julie R. Jones	12
5	Apolipoprotein E DNA methylation and posttraumatic stress disorder are associated with plasma ApoE level: A preliminary study 2018 ·Behavioural Brain Research ·David A. Nielsen,Catherine J. Spellicy,Mark J. Harding,David P. Graham	10
6	Key apoptotic genes APAF1 and CASP9 implicated in recurrent folate-resistant neural tube defects 2018 ·European Journal of Human Genetics ·Catherine J. Spellicy,Joy Norris,Renee Bend,Caleb Bupp,(unknown),Tracy Reynolds,Jane H. Dean,Yunhui Peng,Emil Alexov,Charles E. Schwartz,(unknown),Michael J. Friez	17
7	Biallelic deletions of the Waardenburg II syndrome gene, SOX10, cause a recognizable arthrogryposis syndrome 2018 ·American Journal of Medical Genetics Part A ·Roger E. Stevenson,Victoria Vincent,Catherine J. Spellicy,Michael J. Friez,Alka Chaubey	6
8	Transgenerational Inheritance of Familial Lipomyelomeningocele 2017 ·Journal of Child Neurology ·(unknown),Ramin Eskandari,Kenton R. Holden,Amy Chen,Catherine J. Spellicy,Julie R. Jones,Jennifer A. Lee,Michael J. Lyons	1
9	Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders 2015 ·Pharmacogenetics and Genomics ·(unknown),David A. Nielsen,Catherine J. Spellicy,Sara Hamon,(unknown),Daisy G.Y. Thompson-Lake,(unknown),James J. Mahoney,Thomas R. Kosten,Thomas F. Newton,Richard De La Garza	15
10	Pharmacogenetics of Addiction Therapy 2014 ·Methods in molecular biology ·David A. Nielsen,(unknown),(unknown),Catherine J. Spellicy	12
11	The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency 2013 ·Frontiers in Psychiatry ·Catherine J. Spellicy,Thomas R. Kosten,Sara Hamon,Mark J. Harding,David A. Nielsen	12
12	ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse 2013 ·Pharmacogenetics and Genomics ·Catherine J. Spellicy,Thomas R. Kosten,Sara Hamon,Mark J. Harding,David A. Nielsen	24
13	Folate Metabolism Gene 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Is Associated with ADHD in Myelomeningocele Patients 2012 ·PLoS ONE ·Catherine J. Spellicy,Hope Northrup,Jack Μ. Fletcher,Paul T. Cirino,Maureen Dennis,Alanna C. Morrison,(unknown),Kit Sing Au	13
14	Investigating the Mechanism of Disease in the RP10 Form of Retinitis Pigmentosa 2009 ·Advances in experimental medicine and biology ·Catherine J. Spellicy,Dong Xu,(unknown),Lizbeth Hedstrom,Sara J. Bowne,Lori S. Sullivan,Stephen P. Daiger	3
15	Retinal isoforms of inosine 5′-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins 2008 ·Archives of Biochemistry and Biophysics ·Dong Xu,(unknown),Catherine J. Spellicy,Sara J. Bowne,Stephen P. Daiger,Lizbeth Hedstrom	15
16	Characterization of retinal inosine monophosphate dehydrogenase 1 in several mammalian species. 2007 ·PubMed ·Catherine J. Spellicy,Stephen P. Daiger,Lori S. Sullivan,Jingya Zhu,Qin Liu,Eric A. Pierce,Sara J. Bowne	22
17	Prevalence of Disease-Causing Mutations in Families with Autosomal Dominant Retinitis Pigmentosa: A Screen of Known Genes in 200 Families 2006 ·Investigative Ophthalmology & Visual Science ·Lori S. Sullivan,Sara J. Bowne,David G. Birch,Dianna K. Hughbanks-Wheaton,John R. Heckenlively,Richard A. Lewis,Charles García,Robert R. German,Susan H. Blanton,Hope Northrup,Anisa Gire,(unknown),Hatice Duzkale,Catherine J. Spellicy,Jingya Zhu,Suma P. Shankar,Stephen P. Daiger	220
18	Why Do Mutations in the Ubiquitously Expressed Housekeeping GeneIMPDH1Cause Retina-Specific Photoreceptor Degeneration? 2006 ·Investigative Ophthalmology & Visual Science ·Sara J. Bowne,Qin Liu,Lori S. Sullivan,Jingya Zhu,Catherine J. Spellicy,Catherine Bowes Rickman,Eric A. Pierce,Stephen P. Daiger	46
19	Phenotypic Characterization of a Large Family With RP10 Autosomal-Dominant Retinitis Pigmentosa: An Asp226Asn Mutation in the IMPDH1 Gene 2005 ·American Journal of Ophthalmology ·Petra Kozma,Dianna K. Hughbanks-Wheaton,Kirsten G. Locke,(unknown),Anisa Gire,Catherine J. Spellicy,Lori S. Sullivan,Sara J. Bowne,Stephen P. Daiger,David G. Birch	16
20	Spectrum and Frequency of Mutations in IMPDH1 Associated with Autosomal Dominant Retinitis Pigmentosa and Leber Congenital Amaurosis 2005 ·Investigative Ophthalmology & Visual Science ·Sara J. Bowne,Lori S. Sullivan,Sarah Mortimer,Lizbeth Hedstrom,Jingya Zhu,Catherine J. Spellicy,Anisa Gire,Dianna K. Hughbanks-Wheaton,David G. Birch,Richard A. Lewis,John R. Heckenlively,Stephen P. Daiger	117

About Catherine J. Spellicy

Catherine J. Spellicy is a scholar working on Ophthalmology, Epidemiology and Cellular and Molecular Neuroscience, having authored 20 papers that have together received 587 indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Ophthalmology (149 citations), Physiology (41 citations) and Molecular Biology (484 citations). Catherine J. Spellicy has collaborated with scholars based in United States, Cyprus and Canada. Frequent co-authors include Stephen P. Daiger, Sara J. Bowne, Lori S. Sullivan, Jingya Zhu, David G. Birch, Anisa Gire, Dianna K. Hughbanks-Wheaton, John R. Heckenlively, Richard A. Lewis and David A. Nielsen. Their work appears in journals such as PLoS ONE, Archives of Biochemistry and Biophysics and American Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact